A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial.

Name: A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial.
Author: Gisslinger, Heinz

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial. — المؤلف: Gisslinger, Heinz — British journal of haematology 20200501

المؤلف: Gisslinger, Heinz
النشر: British journal of haematology 20200501
الوصف: 691-700 p.
الموضوعات: Delayed-Action Preparations؛ Dose-Response Relationship, Drug؛ Double-Blind Method؛ Drug Compounding؛ Female؛ Humans؛ Male؛ Middle Aged